Ranbaxy launches pravastatin sodium tablets in US
June 25 : Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases.
Archive for the Biotech Business Articles
After olive oil, Dalmia Continental promotes hazelnuts
June 22 : Positioning hazelnuts as the “ultimate healthy snack”, a leading Indian company has begun marketing the “miracle nut from Turkey” in the country, hoping to replicate its success in promoting olive oil.
Shantha Biotechnics to triple vaccine filling capacity
May 26 : Shantha Biotechnics, the first Indian company to develop, manufacture and market a recombinant human healthcare product in the country, Saturday opened its new state-of-the-art high speed vaccine vial filling facility.
Nautilus awarded record $1 million order by Talwalkars
Mumbai, May 15, 2007 : US-based fitness giant Nautilus has been awarded a record order worth over $1 million by Talwalkars, India’s largest chain of health centres. This is the biggest ever order placed with a single fitness equipment company in India.
Brazil bypasses US giant for Indian drugs
May 5 : Brazilian President Luiz Inacio Lula da Silva has allowed his country to ignore US pharmaceutical giant Merck’s patent on AIDS drug Efavirenz and opted for a cheaper generic alternative from India.
Generic versions of medicines may not be cheaper than brand name products
May 2 : According to research from professors at Duke University’s Fuqua School of Business, generic versions of a class of medicines called ‘biologics’ would not be significantly cheaper than brand-name versions of the medicines.
Biocon profits surge 15 percent for 2006-07
Bangalore, April 19 : Indian biotechnology major Biocon Ltd. Thursday announced a 15 percent surge in its profit at Rs.2 billion with a total income at Rs.9.9 billion in fiscal 2006-07.
India’s pharmaceutical industry to be global player: study
Berlin, April 16 - India’s pharmaceutical companies are gearing up to become a major global player, not only in producing low-price generic medicines but also as innovators in drugs and vaccines, according to a study.
Dabur shuts down research project in Nepal
Kathmandu, Jan 3 - Dabur Nepal, a wholly-owned subsidiary of Dabur India and one of the kingdom’s biggest exporters, Wednesday announced it was shutting down its NRS 100-million greenhouse growing rare medicinal herbs due to harassment by Maoist insurgents.
Ranbaxy gets US approval for generic hypertension drug
New Delhi, Jan 2 - Indian pharma major Ranbaxy Laboratories Limited has received the approval from the US Food and Drug Administration (FDA) to manufacture and market generic hypertension drug Atenolol in the country.